Xiaofei An

871 total citations
19 papers, 690 citations indexed

About

Xiaofei An is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Immunology. According to data from OpenAlex, Xiaofei An has authored 19 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Immunology. Recurrent topics in Xiaofei An's work include Pharmacology and Obesity Treatment (2 papers), Inflammasome and immune disorders (2 papers) and Hormonal and reproductive studies (2 papers). Xiaofei An is often cited by papers focused on Pharmacology and Obesity Treatment (2 papers), Inflammasome and immune disorders (2 papers) and Hormonal and reproductive studies (2 papers). Xiaofei An collaborates with scholars based in China and United States. Xiaofei An's co-authors include Jin‐an Zhang, Qiuming Yao, Yuqing Huo, Chaodong Wu, Honggui Li, Xin Guo, Sridhar Kandala, Md Nasrul Hoda, Yunchao Su and Xizhen Xu and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Xiaofei An

16 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei An China 10 373 127 120 105 103 19 690
Qian Ge China 17 276 0.7× 153 1.2× 69 0.6× 148 1.4× 168 1.6× 59 878
Lingshu Wang China 13 277 0.7× 65 0.5× 89 0.7× 102 1.0× 153 1.5× 21 549
Xiao Chuan-shi China 15 321 0.9× 237 1.9× 74 0.6× 121 1.2× 55 0.5× 34 820
Zhen Sun China 17 319 0.9× 80 0.6× 112 0.9× 170 1.6× 119 1.2× 41 812
Chengxu Ma China 12 298 0.8× 97 0.8× 133 1.1× 71 0.7× 61 0.6× 26 624
Xiaoqing Yi China 18 508 1.4× 219 1.7× 42 0.3× 119 1.1× 115 1.1× 45 913
Giovanna Piraino United States 18 357 1.0× 92 0.7× 68 0.6× 208 2.0× 92 0.9× 37 827
Guangyi Liu China 14 351 0.9× 96 0.8× 48 0.4× 95 0.9× 65 0.6× 30 871
Preeti Kanikarla Marie United States 16 260 0.7× 121 1.0× 118 1.0× 71 0.7× 191 1.9× 28 803
Feng‐Bin Lu China 10 295 0.8× 150 1.2× 139 1.2× 331 3.2× 86 0.8× 11 691

Countries citing papers authored by Xiaofei An

Since Specialization
Citations

This map shows the geographic impact of Xiaofei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei An more than expected).

Fields of papers citing papers by Xiaofei An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei An. The network helps show where Xiaofei An may publish in the future.

Co-authorship network of co-authors of Xiaofei An

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei An. A scholar is included among the top collaborators of Xiaofei An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei An. Xiaofei An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gu, Yanping, et al.. (2025). Activation of bitter taste receptor TAS2R4 alleviates diabetic nephropathy in mice. Biochemical Pharmacology. 237. 116941–116941.
2.
An, Xiaofei, et al.. (2025). Translational study of targeting Dynamin-1 and podocyte actin cytoskeleton to reduce proteinuria in chronic kidney disease. European Journal of Pharmacology. 1007. 178237–178237.
3.
4.
Song, Mingming, Shuqi Dong, Xiaofei An, et al.. (2022). Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers. Journal of Controlled Release. 345. 744–754. 41 indexed citations
5.
Zhou, Wei, Minmin Chen, Wenhui Wu, et al.. (2022). Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho. Acta Pharmacologica Sinica. 43(10). 2609–2623. 34 indexed citations
6.
Zhou, Yuexin, et al.. (2022). The occurrence of hypogonadotropic hypogonadism in Chinese men with type 2 diabetes. Clinical Endocrinology. 96(6). 837–846. 1 indexed citations
7.
Shi, Yujie, Yonghong Xiong, Shiyao Zhang, et al.. (2021). Host Gasdermin D restrains systemic endotoxemia by capturing Proteobacteria in the colon of high-fat diet-feeding mice. Gut Microbes. 13(1). 1946369–1946369. 32 indexed citations
8.
Wang, Hao, Xiaofei An, Junhan Zhang, et al.. (2021). Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: Implications for gout therapy. Phytomedicine. 84. 153521–153521. 31 indexed citations
9.
Zhang, Junhan, Ji-Qin Hou, Hao Wang, et al.. (2021). Frutescone O from Baeckea frutescens Blocked TLR4-Mediated Myd88/NF-κB and MAPK Signaling Pathways in LPS Induced RAW264.7 Macrophages. Frontiers in Pharmacology. 12. 643188–643188. 10 indexed citations
10.
Zhao, Yue, Yu Xu, Xinyi Sun, et al.. (2020). Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF. Evidence-based Complementary and Alternative Medicine. 2020(1). 5204917–5204917. 4 indexed citations
11.
Ni, Yan, Kaida Mu, Xiaofei An, et al.. (2019). Aberrant Histone Methylation in Patients with Graves’ Disease. International Journal of Endocrinology. 2019. 1–7. 8 indexed citations
12.
Shao, Xiaoqing, Bin Wang, Ling Li, et al.. (2017). Antibiotic Exposure in Early Life Increases Risk of Childhood Obesity: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 8. 170–170. 71 indexed citations
13.
Yao, Qiuming, et al.. (2017). Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis. Endocrine Connections. 7(1). 220–231. 64 indexed citations
14.
Yao, Qiuming, Jie Li, Xiaofei An, et al.. (2017). Association between C1q gene polymorphisms and autoimmune thyroid diseases. Archives of Endocrinology and Metabolism. 61(4). 337–342. 5 indexed citations
15.
An, Xiaofei, et al.. (2016). [Treatment of Early Diabetic Retinopathy by Liuwei Dihuang Pill Combined Ginkao Leaf Tablet].. PubMed. 36(6). 674–7. 4 indexed citations
16.
Woo, Shih-Lung, Hang Xu, Honggui Li, et al.. (2014). Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity. PLoS ONE. 9(3). e91111–e91111. 160 indexed citations
17.
Xu, Yiming, Xiaofei An, Xin Guo, et al.. (2014). Endothelial PFKFB3 Plays a Critical Role in Angiogenesis. Arteriosclerosis Thrombosis and Vascular Biology. 34(6). 1231–1239. 201 indexed citations
18.
Wei, Shujian, Huan Wang, Guoying Zhang, et al.. (2012). Platelet IκB Kinase-β Deficiency Increases Mouse Arterial Neointima Formation via Delayed Glycoprotein Ibα Shedding. Arteriosclerosis Thrombosis and Vascular Biology. 33(2). 241–248. 23 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qian Ge Breakdown of academic impact, for papers by Lingshu Wang Breakdown of academic impact, for papers by Xiao Chuan-shi Breakdown of academic impact, for papers by Zhen Sun Breakdown of academic impact, for papers by Chengxu Ma Breakdown of academic impact, for papers by Xiaoqing Yi Breakdown of academic impact, for papers by Giovanna Piraino Breakdown of academic impact, for papers by Guangyi Liu Breakdown of academic impact, for papers by Preeti Kanikarla Marie Breakdown of academic impact, for papers by Feng‐Bin Lu
Rankless by CCL
2026